Interacting Drugs |
Lidocaine and hydrocortisone vs CYP3A4 Substrates |
Security Level |
 |
Mechanism |
CYP3A4 Substrates: CYP3A4 Inhibitors (Moderate) may decrease the metabolism of CYP3A4 Substrates. |
Management |
Monitor therapy |
Lidocaine and hydrocortisone vs CYP3A4 Substrates
Post Review about Lidocaine and hydrocortisone vs CYP3A4 Substrates Click here to cancel reply.
Other Interactions of Lidocaine and hydrocortisone
Other Interactions of CYP3A4 Substrates
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.